RXRX
Companies
NASDAQ
Recursion Pharmaceuticals Inc.
Health Care
$5.11
-$1.65 (-24.41%)
Price Chart
Overview
About RXRX
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Market Cap
$2.0B
Volume
101.7M
Avg. Volume
113.2M
P/E Ratio
-2.5300577
Dividend Yield
0.00%
Employees
507.0
Company Information
Latest News for RXRX
Recursion Pharmaceuticals' Update Could Shed Light On Pipeline, Cost-Saving Plans, Analyst Says
March 3, 2025
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
October 2, 2024
Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors
June 20, 2025
Risk & Correlation Analysis
Market Correlation
1.57
High Correlation
Volatility
High (0.95)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, RXRX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.0B
Volume101.7M
P/E Ratio-2.53
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 5, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025